Encision: Funding, Investors & Team (Sep 2026)
Encision, a US-based medical device company, creates and sells patented surgical instruments, specifically Active Electrode Monitoring (AEM) instruments, to improve electrosurgery and lower the risk of patient harm in minimally invasive procedures. Their product range includes articulating instruments, fixed-tip electrodes, and handles designed for advanced laparoscopic surgeries. They also offer an AEM monitor product line to be used alongside their instruments. Encision primarily sells its products to hospitals through their network of sales representatives. The company was established in 1991 and is headquartered in Boulder, Colorado.
Encision has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in Aug 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Encision Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Encision Funding Rounds
Encision Founders and Leadership Team
No contact details are on record for this team yet.
Encision Funding Compared to Other Biotechnology Startups
Encision's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Encision in Biotechnology and Boulder
Companies Similar to Encision
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Encision Funding FAQs
What does Encision do?
Encision, a US-based medical device company, creates and sells patented surgical instruments, specifically Active Electrode Monitoring (AEM) instruments, to improve electrosurgery and lower the risk of patient harm in minimally invasive procedures. Their product range includes articulating instruments, fixed-tip electrodes, and handles designed for advanced laparoscopic surgeries. They also offer an AEM monitor product line to be used alongside their instruments. Encision primarily sells its products to hospitals through their network of sales representatives. The company was established in 1991 and is headquartered in Boulder, Colorado.
How much funding has Encision raised?
Encision has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in Aug 2025.
When did Encision last raise funding?
Encision's most recent funding round on record is an undisclosed round of $500k, announced in Aug 2025.
Who founded Encision?
FundedIQ lists Roger C Odell (Founder) at Encision.
Where is Encision headquartered?
Encision is based in Boulder, Colorado, United States.
How many employees does Encision have?
Encision is in the 51-100 employee band.
How does Encision's funding compare to other Biotechnology startups?
Encision's latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Encision Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Encision is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.